Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catheter Precision (VTAK) Treasury Shares (2018 - 2025)

Catheter Precision (VTAK) has disclosed Treasury Shares for 7 consecutive years, with $6000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Treasury Shares changed N/A to $6000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $6000.0, a N/A change, with the full-year FY2022 number at $61.0, down 95.65% from a year prior.
  • Treasury Shares was $6000.0 for Q3 2025 at Catheter Precision, down from $50001.0 in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $351848.0 in Q2 2021 to a low of $26.0 in Q1 2023.
  • A 4-year average of $77093.5 and a median of $4875.0 in 2021 define the central range for Treasury Shares.
  • Biggest YoY gain for Treasury Shares was 34566.67% in 2023; the steepest drop was 99.98% in 2023.
  • Catheter Precision's Treasury Shares stood at $1402.0 in 2021, then crashed by 95.65% to $61.0 in 2022, then surged by 42522.95% to $26000.0 in 2023, then tumbled by 76.92% to $6000.0 in 2025.
  • Per Business Quant, the three most recent readings for VTAK's Treasury Shares are $6000.0 (Q3 2025), $50001.0 (Q1 2025), and $26000.0 (Q3 2023).